Earnings Call · Q4 FY2022·2023-03-25

Q4 22EPS +35.90%·Rev n/aQ3 22EPS -13.51%·Rev n/aQ2 22EPS +6.00%·Rev n/aQ1 22EPS -62.50%·Rev n/a⚠ consensus missing

Invivyd, Inc. IVVD

Kyra Faircloth — Vice President, Advocacy and Corporate Communications

Dave Hering — Chief Executive Officer

Pete Schmidt — Head of Clinical Development

Lukas Dillinger — Head of Research and Development

Fred Driscoll — Chief Financial Officer

−8.4%1d on move date−9.0% vs SPY3d−5.6%5d−17.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IVVD calls or request research access.

More IVVD calls Browse calls Request research access